Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1186/1477-7819-10-130.

Title:
Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy | World Journal of Surgical Oncology
Description:
Background The effects of transthoracic or transhiatal esophagectomy on the long-term survival of patients who had adenocarcinoma of the esophagus were compared, as were factors applicable in preoperative stratification of patient treatment. Methods A cohort of 147 consecutive patients with adenocarcinoma of the esophagus was evaluated for esophagectomy between 1984 and 2000. The patients were followed prospectively and observed survival rates of patients with a transthoracic or transhiatal approach to esophagectomy were compared by standardized mortality ratio (SMR) and relative mortality ratio (RMR) using the expected survival of a matched Norwegian population. Results A R0 resection was performed by transthoracic (n = 33) or a transhiatal (n = 55) esophagectomy in 88 (60%) patients with a median age of 61 (range: 35–77) and 70 (42–88) years, respectively (P < 0.001). Tumor stages and other possible risk factors were similar in the two groups. Transthoracic or transhiatal esophagectomy resulted in a median survival time of 20.5 (95% confidence interval (CI): 10.4–57.6) and 16.4 (10.6–28.7) months, respectively. The respective survival rates were 31.2% and 27.8% by 5 years, and 21.3% and 16.6% by 10 years with an overall RMR of 1.14 (P = 0.63). Median survival time in the absence or presence of lymph node metastases was 74.0 (95% CI: 17.5–166.4) and 10.7 (7.9–14.9) months. The corresponding survival rates by 10 years with non-involved or involved nodes were 48.9% and 3.8% respectively (RMR 2.22, P = 0.007). Patients with a pT1-tumor were few and the survival rate was not very different from that of the general population (SMR = 1.7, 95% CI: 0.7–4.1). The median survival time of patients with a pT2-tumor was 30.4 (95% CI: 9.0–142) months and with a pT3-tumor 14 (9.2–16.4) months. The survival rates by 10 years among patients with a pT1 tumor were 57.0% (95% CI: 14.9–78.9), pT2 33.3% (11.8–52.2), and pT3 7.1% (1.9–15.5). The relative mortality for T3 stages compared to T1 stages was statistically significant (RMR = 3.22, P = 0.024). Conclusion Transthoracic and transhiatal esophagectomy are both effective approaches for treatment of adenocarcinoma of the esophagus and survival of more than 10 years can be expected without adjuvant chemotherapy. However, increasing depth of tumor invasion and lymph node metastases reduce life expectancy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Insurance
  • Education

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We find it hard to spot revenue streams.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {πŸ”}

patients, survival, esophagectomy, transhiatal, transthoracic, lymph, adenocarcinoma, esophagus, article, pubmed, google, scholar, mortality, node, rates, metastases, surgical, surg, years, table, treatment, resection, tumor, esophageal, study, nodes, population, cancer, median, age, rate, stage, dissection, number, months, cas, approach, tumors, smr, time, surgery, disease, compared, similar, involved, limited, classification, ann, patient, observed,

Topics {βœ’οΈ}

8f-fluorodeoxyglucose-positron emission tomography convey long-term survival article download pdf full size image longer life expectancy shorter life expectancy de boer ag privacy choices/manage cookies hulscher jb en bloc lymphadenectomy health research ethics matched norwegian population long-term survival standardized mortality ratio en bloc esophagectomy long-term prognosis lymph node involvement authors’ original file lymph node metastases lymph node dissection full access lymph node status allowed oral feeding chi-square tests positron emission tomography relative mortality ratio surgical oncology aims retrieved lymph nodes examined lymph nodes involved lymph nodes lymph nodes sampled surgery-related deaths occurred prolonged ventilator support removed en bloc lymph nodes metastases lymph node stages long-term results 5-year prospective cohort van lanschot jj biomed central minimal invasive approaches poor health obviated natl cancer inst gastrointest cancer res circular stapling instrument transabdominal jejunal catheter routine formaldehyde fixation parametric mann-tests whitney u-test fisher exact test

Questions {❓}

  • Bogoevski D, Onken F, Koenig A, Kaifi JT, Schurr P, Sauter G, Izbicki JR, Yekebas EF: Is it time for a new TNM classification in esophageal carcinoma?
  • Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T: Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis?
  • Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ, Whang EE: Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy
         description:The effects of transthoracic or transhiatal esophagectomy on the long-term survival of patients who had adenocarcinoma of the esophagus were compared, as were factors applicable in preoperative stratification of patient treatment. A cohort of 147 consecutive patients with adenocarcinoma of the esophagus was evaluated for esophagectomy between 1984 and 2000. The patients were followed prospectively and observed survival rates of patients with a transthoracic or transhiatal approach to esophagectomy were compared by standardized mortality ratio (SMR) and relative mortality ratio (RMR) using the expected survival of a matched Norwegian population. A R0 resection was performed by transthoracic (n = 33) or a transhiatal (n = 55) esophagectomy in 88 (60%) patients with a median age of 61 (range: 35–77) and 70 (42–88) years, respectively (P &lt; 0.001). Tumor stages and other possible risk factors were similar in the two groups. Transthoracic or transhiatal esophagectomy resulted in a median survival time of 20.5 (95% confidence interval (CI): 10.4–57.6) and 16.4 (10.6–28.7) months, respectively. The respective survival rates were 31.2% and 27.8% by 5 years, and 21.3% and 16.6% by 10 years with an overall RMR of 1.14 (P = 0.63). Median survival time in the absence or presence of lymph node metastases was 74.0 (95% CI: 17.5–166.4) and 10.7 (7.9–14.9) months. The corresponding survival rates by 10 years with non-involved or involved nodes were 48.9% and 3.8% respectively (RMR 2.22, P = 0.007). Patients with a pT1-tumor were few and the survival rate was not very different from that of the general population (SMR = 1.7, 95% CI: 0.7–4.1). The median survival time of patients with a pT2-tumor was 30.4 (95% CI: 9.0–142) months and with a pT3-tumor 14 (9.2–16.4) months. The survival rates by 10 years among patients with a pT1 tumor were 57.0% (95% CI: 14.9–78.9), pT2 33.3% (11.8–52.2), and pT3 7.1% (1.9–15.5). The relative mortality for T3 stages compared to T1 stages was statistically significant (RMR = 3.22, P = 0.024). Transthoracic and transhiatal esophagectomy are both effective approaches for treatment of adenocarcinoma of the esophagus and survival of more than 10 years can be expected without adjuvant chemotherapy. However, increasing depth of tumor invasion and lymph node metastases reduce life expectancy.
         datePublished:2012-06-30T00:00:00Z
         dateModified:2012-06-30T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1477-7819-10-130
         keywords:
            Standardize Mortality Ratio
            Distal Esophagus
            Transhiatal Esophagectomy
            Transthoracic Esophagectomy
            Examine Lymph Node
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1477-7819-10-130/MediaObjects/12957_2012_Article_1058_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1477-7819-10-130/MediaObjects/12957_2012_Article_1058_Fig2_HTML.jpg
         isPartOf:
            name:World Journal of Surgical Oncology
            issn:
               1477-7819
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kjell K Ovrebo
               affiliation:
                     name:Haukeland University Hospital
                     address:
                        name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Stein A Lie
               affiliation:
                     name:University of Bergen
                     address:
                        name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:Uni Health, Uni Research
                     address:
                        name:Uni Health, Uni Research, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ole D Laerum
               affiliation:
                     name:University of Bergen, Haukeland University Hospital
                     address:
                        name:Department of Pathology, The Gade Institute, Section of Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Knut Svanes
               affiliation:
                     name:Haukeland University Hospital
                     address:
                        name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Asgaut Viste
               affiliation:
                     name:Haukeland University Hospital
                     address:
                        name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                        type:PostalAddress
                     type:Organization
                     name:University of Bergen
                     address:
                        name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Long-term survival from adenocarcinoma of the esophagus after transthoracic and transhiatal esophagectomy
      description:The effects of transthoracic or transhiatal esophagectomy on the long-term survival of patients who had adenocarcinoma of the esophagus were compared, as were factors applicable in preoperative stratification of patient treatment. A cohort of 147 consecutive patients with adenocarcinoma of the esophagus was evaluated for esophagectomy between 1984 and 2000. The patients were followed prospectively and observed survival rates of patients with a transthoracic or transhiatal approach to esophagectomy were compared by standardized mortality ratio (SMR) and relative mortality ratio (RMR) using the expected survival of a matched Norwegian population. A R0 resection was performed by transthoracic (n = 33) or a transhiatal (n = 55) esophagectomy in 88 (60%) patients with a median age of 61 (range: 35–77) and 70 (42–88) years, respectively (P &lt; 0.001). Tumor stages and other possible risk factors were similar in the two groups. Transthoracic or transhiatal esophagectomy resulted in a median survival time of 20.5 (95% confidence interval (CI): 10.4–57.6) and 16.4 (10.6–28.7) months, respectively. The respective survival rates were 31.2% and 27.8% by 5 years, and 21.3% and 16.6% by 10 years with an overall RMR of 1.14 (P = 0.63). Median survival time in the absence or presence of lymph node metastases was 74.0 (95% CI: 17.5–166.4) and 10.7 (7.9–14.9) months. The corresponding survival rates by 10 years with non-involved or involved nodes were 48.9% and 3.8% respectively (RMR 2.22, P = 0.007). Patients with a pT1-tumor were few and the survival rate was not very different from that of the general population (SMR = 1.7, 95% CI: 0.7–4.1). The median survival time of patients with a pT2-tumor was 30.4 (95% CI: 9.0–142) months and with a pT3-tumor 14 (9.2–16.4) months. The survival rates by 10 years among patients with a pT1 tumor were 57.0% (95% CI: 14.9–78.9), pT2 33.3% (11.8–52.2), and pT3 7.1% (1.9–15.5). The relative mortality for T3 stages compared to T1 stages was statistically significant (RMR = 3.22, P = 0.024). Transthoracic and transhiatal esophagectomy are both effective approaches for treatment of adenocarcinoma of the esophagus and survival of more than 10 years can be expected without adjuvant chemotherapy. However, increasing depth of tumor invasion and lymph node metastases reduce life expectancy.
      datePublished:2012-06-30T00:00:00Z
      dateModified:2012-06-30T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1477-7819-10-130
      keywords:
         Standardize Mortality Ratio
         Distal Esophagus
         Transhiatal Esophagectomy
         Transthoracic Esophagectomy
         Examine Lymph Node
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1477-7819-10-130/MediaObjects/12957_2012_Article_1058_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1477-7819-10-130/MediaObjects/12957_2012_Article_1058_Fig2_HTML.jpg
      isPartOf:
         name:World Journal of Surgical Oncology
         issn:
            1477-7819
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kjell K Ovrebo
            affiliation:
                  name:Haukeland University Hospital
                  address:
                     name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Stein A Lie
            affiliation:
                  name:University of Bergen
                  address:
                     name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:Uni Health, Uni Research
                  address:
                     name:Uni Health, Uni Research, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ole D Laerum
            affiliation:
                  name:University of Bergen, Haukeland University Hospital
                  address:
                     name:Department of Pathology, The Gade Institute, Section of Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Knut Svanes
            affiliation:
                  name:Haukeland University Hospital
                  address:
                     name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Asgaut Viste
            affiliation:
                  name:Haukeland University Hospital
                  address:
                     name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
                     type:PostalAddress
                  type:Organization
                  name:University of Bergen
                  address:
                     name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:World Journal of Surgical Oncology
      issn:
         1477-7819
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Haukeland University Hospital
      address:
         name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Uni Health, Uni Research
      address:
         name:Uni Health, Uni Research, Bergen, Norway
         type:PostalAddress
      name:University of Bergen, Haukeland University Hospital
      address:
         name:Department of Pathology, The Gade Institute, Section of Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
         type:PostalAddress
      name:Haukeland University Hospital
      address:
         name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
         type:PostalAddress
      name:Haukeland University Hospital
      address:
         name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
         type:PostalAddress
      name:University of Bergen
      address:
         name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kjell K Ovrebo
      affiliation:
            name:Haukeland University Hospital
            address:
               name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Stein A Lie
      affiliation:
            name:University of Bergen
            address:
               name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:Uni Health, Uni Research
            address:
               name:Uni Health, Uni Research, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Ole D Laerum
      affiliation:
            name:University of Bergen, Haukeland University Hospital
            address:
               name:Department of Pathology, The Gade Institute, Section of Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Knut Svanes
      affiliation:
            name:Haukeland University Hospital
            address:
               name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
      name:Asgaut Viste
      affiliation:
            name:Haukeland University Hospital
            address:
               name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
               type:PostalAddress
            type:Organization
            name:University of Bergen
            address:
               name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
      name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
      name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
      name:Uni Health, Uni Research, Bergen, Norway
      name:Department of Pathology, The Gade Institute, Section of Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway
      name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
      name:Department of Surgical Sciences, University of Bergen, Bergen, Norway
      name:Department of Surgery, Haukeland University Hospital, Bergen, Norway
      name:Department of Surgical Sciences, University of Bergen, Bergen, Norway

External Links {πŸ”—}(156)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

5.45s.